Drugs / M1 Pram P037
last change Feb 2022 re-read 2 minutes ago

M1 Pram P037

Developed for
type 1 diabetes mellitus
Investigated by
Adocia

Trials 1 · a red edge is where a trial was stopped

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04816890 Mar 2021 → Feb 2022 type 1 diabetes mellitus Adocia Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as M1 Pram P037 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04816890
Route Subcutaneous Subcutaneous administration of M1 Pram P037 in combination with a basal insulin.” NCT04816890